Sponsor Pipeline

Australasian Leukaemia and Lymphoma Group Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-30 NCT07736950 A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07736950 A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without… Follicular Lymphoma Not Yet Recruiting
Phase 2
NCT05833763 A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With… Mantle Cell Lymphoma Recruiting
NCT06287398 Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor… DLBCL - Diffuse Large B Cell Lymphoma Recruiting
Disease Areas
Mantle Cell Lymphoma (1) DLBCL (1) Follicular Lymphoma (1)
Get alerts when Australasian Leukaemia and Lymphoma Group's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free